Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129675) titled 'Multimodal Ultrasound Artificial Intelligence Model for Assessing the Feasibility of Exempting Sentinel Lymph Node Biopsy in Early Breast Cancer' on Aug. 7.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
Breast cancer
Intervention:
Gold Standard:Postoperative histopathological examination of axillary lymph nodes (including pathological results from paraffin sections of sentinel lymph node biopsy and axillary lymph node dissection), to determine the presence of isolated tumor cells, micrometastasis, or macrometastasis.
R...